InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Rhode Peter, 管理人员. Officer active across 1 company, notably HCW Biologics Inc.. Aggregated, 4 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €85k. Activity tracked since 22 July 2021. The latest transaction was disclosed on 11 December 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Peter Rhode is an Executive at HCW Biologics Inc. While his specific role is not detailed, he contributes to the leadership and management of the company's operations. Peter is involved in making strategic decisions that influence the organization's performance and growth. His expertise is essential for the development of the company's initiatives.